Health & Wellness
Monday, June 1, 2026 · Perry & Dallas Region
Some Jurisdictions Curtail Public Health Powers Following Pandemic Disputes
Several jurisdictions have restricted the powers of their public health agencies following backlash over pandemic-era policies. The changes come amid ongoing debates over lockdowns, mask mandates, and vaccine requirements.
Weekly Semaglutide Improves Quality of Life for Patients With Diabetes and Kidney Disease
Researchers presenting findings from the FLOW trial at the 63rd European Renal Association Congress reported that weekly semaglutide injections improved health-related quality of life measures among adults with diabetes and kidney disease.
Monday, June 1, 2026
Semaglutid improves quality of life for patients with diabetes and kidney disease, study finds
Researchers presenting findings at the ERA Congress in Glasgow reported that weekly semaglutid injections improved health-related quality of life measures in adults with type 2 diabetes and chronic kidney disease.
Monday, June 1, 2026
Semaglutide Study Shows Quality-of-Life Improvements in Diabetic Patients With Kidney Disease
New findings from a major clinical trial indicate that semaglutide improves quality of life in patients who have both type 2 diabetes and chronic kidney disease. Researchers presented the results at a medical conference in Glasgow.
Monday, June 1, 2026
WHO Chief: Congo Ebola Response Still Lagging Despite Testing Gains
The World Health Organization acknowledged Wednesday that Congo's Ebola outbreak maintains an advantage over response teams even as testing capabilities improve. Armed attacks in the region compound the challenge.
Monday, June 1, 2026
Experimental daily pill extends pancreatic cancer survival
Researchers have developed an experimental drug that extends survival for pancreatic cancer patients by slowing disease progression. The once-daily pill represents progress in treating one of the deadliest cancers.
Monday, June 1, 2026
U.S. Coordinates Ebola Response in Central Africa
The U.S. State Department, working with the CDC and regional governments, has committed over $162 million to combat an ongoing Ebola outbreak in Central Africa. The response includes screening operations at border crossings, isolation facilities, and food assistance to affected populations.
Monday, June 1, 2026
Gleevec Marked a Turning Point in Cancer Treatment 23 Years Ago
The Food and Drug Administration (FDA) approved Gleevec for leukemia treatment in 2001, marking a new phase in cancer care. The drug offered a targeted treatment, improving survival rates and quality of life for patients.
Monday, June 1, 2026
Cardiac screening studies find heart conditions in young women at rates comparable to men
Medical researchers have identified cardiac conditions in young women at frequencies similar to those found in young men, according to screening studies. The findings suggest current diagnostic protocols may miss significant numbers of at-risk women.
Monday, June 1, 2026
Experimental pancreatic cancer pill extends survival in advanced cases
Researchers reported Sunday that an experimental pill helped patients with advanced pancreatic cancer survive longer than current treatments allow. The findings offer a potential new option for a disease that kills most patients within months of diagnosis.
Monday, June 1, 2026
Federal Judge to Review $1.8 Billion Compensation Fund for Trump Administration
A federal judge has agreed to review a $1.8 billion fund established by the Trump administration to compensate individuals it says suffered wrongful treatment by the federal government. The fund's announcement sparked opposition across Republican and Democratic ranks.
Monday, June 1, 2026
Experimental Pancreatic Cancer Pill Extends Survival in Clinical Trial
Researchers reported Sunday that an experimental pill extended survival for people with advanced pancreatic cancer, marking a potential advance against one of the most lethal malignancies.
Monday, June 1, 2026
Study shows pancreatic cancer drug doubles survival for majority of patients
A new study found that daraxonrasib doubled survival rates for more than 90 percent of pancreatic cancer patients. Researchers now plan to test the drug against lung, ovarian, and colorectal cancers.
Monday, June 1, 2026
U.S. Commits $162 Million to Ebola Response in Congo and Uganda
The United States has committed $162 million to combat an Ebola outbreak in the Democratic Republic of the Congo and Uganda, making it the largest financial contributor to the response effort. The State Department coordinated with Canada and Mexico on travel screening measures ahead of the 2026 FIFA World Cup.
Monday, June 1, 2026
Overdose cases linked to GLP-1 weight loss drugs prompt scrutiny
NBC News correspondent Anne Thompson reported findings from an investigation into overdose cases associated with GLP-1 drugs used for weight loss. The report, conducted in partnership with KFF Health News, documents a rise in such incidents.
Monday, June 1, 2026
Injectable Immunotherapy Offers Faster Cancer Treatment Option
A new injectable form of immunotherapy could significantly decrease treatment time for thousands of cancer patients. The new method reduces administration time from hours to minutes.
Monday, June 1, 2026
Hantavirus Suspected in Cruise Ship Deaths
Three people aboard a cruise ship in the Atlantic Ocean died after a suspected hantavirus outbreak. Health organizations are investigating the incident, which also left others sickened.
Monday, June 1, 2026
Hantavirus Outbreak on Cruise Ship Kills Three, WHO Reports
The World Health Organization reported three deaths linked to a hantavirus outbreak on a cruise ship in the Atlantic Ocean. Hantaviruses spread through contact with infected rodents. The infections, while rare, can cause severe respiratory illness.
Monday, June 1, 2026
FDA Releases Results of Infant Formula Contaminant Testing
The Food and Drug Administration published findings from its most extensive analysis of chemical contaminants in infant formula sold in the United States. The study examined a range of products available to consumers. The agency plans to use the data to inform future regulatory decisions.
Monday, June 1, 2026
CDC to Brief Public on Swine Influenza Investigation
The Centers for Disease Control and Prevention will hold a briefing to update the public on its investigation into human cases of swine influenza. The briefing is scheduled for Thursday, April 30, 2009, at 11:30 a.m. ET.
Monday, June 1, 2026
U.S. Infant Mortality Rate Declines in Global Ranking
A recent Centers for Disease Control and Prevention report indicated a decline in the United States' global ranking for infant mortality rates. The data compared U.S. rates against those of other nations across several decades. The report tracked changes in the U.S. global position.
Monday, June 1, 2026
Obesity, Diabetes Rates Highest in Parts of South, Appalachia, and Tribal Lands, CDC Estimates
The Centers for Disease Control and Prevention released estimates showing higher rates of obesity and diabetes in specific regions. These include the Southeast, Appalachia, and some tribal lands in the West and Northern Plains. The data underscores geographic health disparities.
Monday, June 1, 2026
Study Links Maternal Obesity to Increased Risk of Infant Heart Defects
A recent study in the United States suggests a correlation between a mother's pre-pregnancy weight and the likelihood of her child developing certain heart defects. Researchers found an increased risk among women classified as overweight or obese before conceiving.
Monday, June 1, 2026
CDC Updates H1N1 Vaccine Recommendations
The Centers for Disease Control and Prevention (CDC) held a press conference to announce updated recommendations regarding the use of the novel influenza A (H1N1) vaccine. The Advisory Committee on Immunization Practices (ACIP) provided the insights leading to the new guidance. Details on specific populations and dosage are expected.
Monday, June 1, 2026
CDC Investigates Human H1N1 Flu Cases
The Centers for Disease Control and Prevention (CDC) is investigating recent human cases of the H1N1 influenza virus. Health authorities are working to understand the virus's characteristics and spread. The CDC is urging the public to take preventative measures.
Monday, June 1, 2026
CDC to Provide Update on Novel H1N1 Influenza Cases
The Centers for Disease Control and Prevention (CDC) will hold a telephone briefing to discuss the ongoing investigation into cases of novel influenza A (H1N1). The briefing will address a new report focused on H1N1 infections among healthcare personnel.
Monday, June 1, 2026
CDC Advisory Panel Issues H1N1 Vaccine Recommendations
Advisors to the Centers for Disease Control and Prevention met to formulate guidelines for distributing the novel H1N1 influenza vaccine. Initial recommendations focus on vaccinating specific populations due to an anticipated scarcity of doses.
Monday, June 1, 2026
Obesity Costs U.S. Healthcare System Up to $147 Billion Annually, Study Finds
A new study estimates the annual medical costs associated with obesity in the United States may reach $147 billion. The Centers for Disease Control and Prevention partnered with the Research Triangle Institute to develop the estimate. The study highlights the significant economic impact of obesity on the nation's healthcare system.
Monday, June 1, 2026
Adult Obesity Rate Rises in United States
The percentage of obese adults in the U.S. increased in 2008, according to new data. The U.S. Centers for Disease Control and Prevention tracked a rise from 25.6% to 26.1%.
Monday, June 1, 2026
Adult Obesity Rate Rises in United States
The percentage of obese adults in the U.S. increased in 2008, according to new data. The U.S. Centers for Disease Control and Prevention tracked a rise from 25.6% to 26.1%.
Monday, June 1, 2026